Riskpilot← Back to searchSign inGet full accessSENJABIO AS
ASActiveOrg 994340360Husøy, 9389 Husøy I SenjaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20090 employees
Revenue 2025
NOK 346K
+300% vs 2024
EBITDA margin
84.2%
+1609% vs 2024
Equity ratio
93.0%
Financial strength
Net profit 2025
NOK 291K
+1600% vs 2024
| Revenue | NOK 346K | +300% |
| EBITDA | NOK 291K | +1609% |
| Net profit | NOK 291K | +1600% |
| Total assets | NOK 1,3M | +39% |
| Equity | NOK 1,2M | +32% |
| Employees | 0 | — |
Legal name
SENJABIO AS
Org number
994340360
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. september 2009
Share capital
NOK 2 250 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Fremme en lønnsom miljøvennlig utnyttelse av biprodukter fra primærnæringen, herunder delta i andre selskaper med lignende virksomhet.
Address
Husøy, 9389 Husøy I Senja
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 216 | 171 | 0 | 86 | 346 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −26 | −10 | −18 | 17 | 291 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −26 | −10 | −18 | 17 | 291 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −25 | −10 | −18 | 17 | 291 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −25 | −10 | −18 | 17 | 291 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 975 | 920 | 905 | 931 | 1 292 |
| Equity | 921 | 911 | 894 | 911 | 1 202 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 54 | 8 | 11 | 20 | 90 |
| Total debt | 54 | 8 | 11 | 20 | 90 |
EBITDA margin
84.2%
This company
15.8%
Market median
+433% vs market
20212025
Equity ratio
93.0%
This company
38.2%
Market median
+143% vs market
20212025
Return on equity
24.2%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
84.2%
This company
8.1%
Market median
+940% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KJ Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2023 | |
| Board of Directors | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 15.56% | 15.56% | 2022 | |
| Company | 15.56% | 15.56% | 2022 | |
| Individual | 11.11% | 11.11% | 2024 | |
| Company | 11.11% | 11.11% | 2022 | |
| Company | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2022 | |
| Company | 8.89% | 8.89% | 2022 | |
| Company | 8.89% | 8.89% | 2022 | |
| Individual | 8.89% | 8.89% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SENJABIO AS 
SENJA BIOGASS UTVIKLING ASBoard members of SENJABIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kato Johansen | Deputy Member | 0 companies |
| Randi Paula Karlsen | Chairman | 0 companies |
| Ørjan Uteng Berntsen | Board of Directors | 0 companies |
| Egil Johansen | Board of Directors | 0 companies |